Cargando…
2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
BACKGROUND: Limited evidence suggests that influenza leads not only to bacterial colonization and greater risk of bacterial pneumonia, but to poor outcomes and increased mortality. We compared bacterial culture results between patients positive (FLU+) and negative (FLU-) for influenza in the setting...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810253/ http://dx.doi.org/10.1093/ofid/ofz360.2470 |
_version_ | 1783462205172219904 |
---|---|
author | Bartley, Patricia Deshpande, Abhishek Yu, Pei-Chun Haessler, Sarah Zilberberg, Marya Imrey, Peter Klompas, Michael Rothberg, Michael |
author_facet | Bartley, Patricia Deshpande, Abhishek Yu, Pei-Chun Haessler, Sarah Zilberberg, Marya Imrey, Peter Klompas, Michael Rothberg, Michael |
author_sort | Bartley, Patricia |
collection | PubMed |
description | BACKGROUND: Limited evidence suggests that influenza leads not only to bacterial colonization and greater risk of bacterial pneumonia, but to poor outcomes and increased mortality. We compared bacterial culture results between patients positive (FLU+) and negative (FLU-) for influenza in the setting of community-acquired pneumonia (CAP). Among FLU+ patients we compared bacterial etiology, characteristics, treatment and outcomes between patients with and without bacterial coinfection. METHODS: We included adults admitted with pneumonia 2010–2015 to 179 US hospitals participating in the Premier database. Pneumonia was identified using an ICD-9-CM algorithm. Among patients tested for FLU, we limited the microbiology results to the first 14 hospital days. We assessed inpatient mortality, ICU admission, use of vasopressors, mechanical ventilation (MV), cost, and LOS using mixed multiple logistic regression and gamma generalized linear mixed models. RESULTS: Among 166,273 patients hospitalized with CAP, 38,665 (23.3%) were tested for influenza and 4,313 (11.15%) were positive. In FLU+ patients the most common bacterial co-infection was Staphylococcus aureus (37.6%) followed by Streptococcus pneumoniae (25.9%) and Pseudomonas aeruginosa (10.9%), varying based on the day of coinfection (days 1–3 vs. days 4–14) (Figure 1). In FLU- patients, S. pneumoniae (30.5%) and S. aureus (30.3%) were similarly common, followed by P. aeruginosa (10.0%). FLU+ patients with bacterial co-infection were younger (66.3 vs. 69.1 years), with more comorbidities (3.2 vs. 2.7) than influenza patients with no bacterial co-infection (all comparisons P < 0.001). Bacterial co-infection was also associated with increased odds of in-hospital mortality (OR 1.86, 95% CI,1.31–2.65), ICU admission (OR 3.46, 2.44–4.9), use of vasopressors (OR 3.74, 2.61–5.36), and MV (OR 3.51, 2.49–5.36), increased cost (risk-adjusted ratio of geometric means, 1.6, (1.47–1.73) and LOS (risk-adjusted ratio of geometric means 1.42, (1.33–1.52). CONCLUSION: In a large US inpatient sample hospitalized for CAP, 11% of patients with influenza had or acquired a bacterial co-infection. Bacterial co-infection was associated with significantly worse outcomes and higher cost. [Image: see text] DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68102532019-10-28 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes Bartley, Patricia Deshpande, Abhishek Yu, Pei-Chun Haessler, Sarah Zilberberg, Marya Imrey, Peter Klompas, Michael Rothberg, Michael Open Forum Infect Dis Abstracts BACKGROUND: Limited evidence suggests that influenza leads not only to bacterial colonization and greater risk of bacterial pneumonia, but to poor outcomes and increased mortality. We compared bacterial culture results between patients positive (FLU+) and negative (FLU-) for influenza in the setting of community-acquired pneumonia (CAP). Among FLU+ patients we compared bacterial etiology, characteristics, treatment and outcomes between patients with and without bacterial coinfection. METHODS: We included adults admitted with pneumonia 2010–2015 to 179 US hospitals participating in the Premier database. Pneumonia was identified using an ICD-9-CM algorithm. Among patients tested for FLU, we limited the microbiology results to the first 14 hospital days. We assessed inpatient mortality, ICU admission, use of vasopressors, mechanical ventilation (MV), cost, and LOS using mixed multiple logistic regression and gamma generalized linear mixed models. RESULTS: Among 166,273 patients hospitalized with CAP, 38,665 (23.3%) were tested for influenza and 4,313 (11.15%) were positive. In FLU+ patients the most common bacterial co-infection was Staphylococcus aureus (37.6%) followed by Streptococcus pneumoniae (25.9%) and Pseudomonas aeruginosa (10.9%), varying based on the day of coinfection (days 1–3 vs. days 4–14) (Figure 1). In FLU- patients, S. pneumoniae (30.5%) and S. aureus (30.3%) were similarly common, followed by P. aeruginosa (10.0%). FLU+ patients with bacterial co-infection were younger (66.3 vs. 69.1 years), with more comorbidities (3.2 vs. 2.7) than influenza patients with no bacterial co-infection (all comparisons P < 0.001). Bacterial co-infection was also associated with increased odds of in-hospital mortality (OR 1.86, 95% CI,1.31–2.65), ICU admission (OR 3.46, 2.44–4.9), use of vasopressors (OR 3.74, 2.61–5.36), and MV (OR 3.51, 2.49–5.36), increased cost (risk-adjusted ratio of geometric means, 1.6, (1.47–1.73) and LOS (risk-adjusted ratio of geometric means 1.42, (1.33–1.52). CONCLUSION: In a large US inpatient sample hospitalized for CAP, 11% of patients with influenza had or acquired a bacterial co-infection. Bacterial co-infection was associated with significantly worse outcomes and higher cost. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810253/ http://dx.doi.org/10.1093/ofid/ofz360.2470 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Bartley, Patricia Deshpande, Abhishek Yu, Pei-Chun Haessler, Sarah Zilberberg, Marya Imrey, Peter Klompas, Michael Rothberg, Michael 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes |
title | 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes |
title_full | 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes |
title_fullStr | 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes |
title_full_unstemmed | 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes |
title_short | 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes |
title_sort | 2793. influenza and bacterial pneumonia coinfection: rates and outcomes |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810253/ http://dx.doi.org/10.1093/ofid/ofz360.2470 |
work_keys_str_mv | AT bartleypatricia 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes AT deshpandeabhishek 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes AT yupeichun 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes AT haesslersarah 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes AT zilberbergmarya 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes AT imreypeter 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes AT klompasmichael 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes AT rothbergmichael 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes |